These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20947571)

  • 1. Assessment of a novel device-based diagnostic algorithm to monitor patient status in moderate-to-severe heart failure: rationale and design of the CLEPSYDRA study.
    Auricchio A; Brugada J; Ellenbogen KA; Gold MR; Leyva F;
    Eur J Heart Fail; 2010 Dec; 12(12):1363-71. PubMed ID: 20947571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.
    Whellan DJ; Ousdigian KT; Al-Khatib SM; Pu W; Sarkar S; Porter CB; Pavri BB; O'Connor CM;
    J Am Coll Cardiol; 2010 Apr; 55(17):1803-10. PubMed ID: 20413029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remote Active Monitoring in Patients with Heart Failure (RAPID-RF): design and rationale.
    Saxon LA; Boehmer JP; Neuman S; Mullin CM
    J Card Fail; 2007 May; 13(4):241-6. PubMed ID: 17517341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate CorRelation to Symptoms in Patients with Heart Failure (PARTNERS HF).
    Whellan DJ; O'Connor CM; Ousdigian KT; Lung TH;
    Am Heart J; 2008 Nov; 156(5):833-9, 839.e2. PubMed ID: 19061695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure.
    Vollmann D; Nägele H; Schauerte P; Wiegand U; Butter C; Zanotto G; Quesada A; Guthmann A; Hill MR; Lamp B;
    Eur Heart J; 2007 Aug; 28(15):1835-40. PubMed ID: 17309902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of a prospective trial to assess the sensitivity and positive predictive value of implantable intrathoracic impedance monitoring in the prediction of heart failure hospitalizations: the SENSE-HF study.
    Cowie MR; Conraads V; Tavazzi L; Yu CM;
    J Card Fail; 2009 Jun; 15(5):394-400. PubMed ID: 19477399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF).
    Braunschweig F; Ford I; Conraads V; Cowie MR; Jondeau G; Kautzner J; Lunati M; Munoz Aguilera R; Man Yu C; Marijianowski M; Borggrefe M; van Veldhuisen DJ;
    Eur J Heart Fail; 2008 Sep; 10(9):907-16. PubMed ID: 18715826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.
    Bourge RC; Abraham WT; Adamson PB; Aaron MF; Aranda JM; Magalski A; Zile MR; Smith AL; Smart FW; O'Shaughnessy MA; Jessup ML; Sparks B; Naftel DL; Stevenson LW;
    J Am Coll Cardiol; 2008 Mar; 51(11):1073-9. PubMed ID: 18342224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Home Monitoring on the clinical status of heart failure patients: Design and rationale of the IN-TIME study.
    Arya A; Block M; Kautzner J; Lewalter T; Mörtel H; Sack S; Schumacher B; Søgaard P; Taborsky M; Husser D; Hindricks G;
    Eur J Heart Fail; 2008 Nov; 10(11):1143-8. PubMed ID: 18805053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proactive monitoring: implications of implantable devices for future heart failure management.
    Daleiden-Burns A; Stiles P
    Crit Care Nurs Q; 2007; 30(4):321-8. PubMed ID: 17873568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can individualized weight monitoring using the HeartPhone algorithm improve sensitivity for clinical deterioration of heart failure?
    Ledwidge MT; O'Hanlon R; Lalor L; Travers B; Edwards N; Kelly D; Voon V; McDonald KM
    Eur J Heart Fail; 2013 Apr; 15(4):447-55. PubMed ID: 23204211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device.
    Adamson PB; Smith AL; Abraham WT; Kleckner KJ; Stadler RW; Shih A; Rhodes MM;
    Circulation; 2004 Oct; 110(16):2389-94. PubMed ID: 15313946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of implantable sensors for management of heart failure.
    Kadhiresan K; Carlson G
    Stud Health Technol Inform; 2004; 108():219-27. PubMed ID: 15718650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.
    Fonarow GC; Abraham WT; Albert NM; Gattis WA; Gheorghiade M; Greenberg B; O'Connor CM; Yancy CW; Young J
    Am Heart J; 2004 Jul; 148(1):43-51. PubMed ID: 15215791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using devices for physiologic monitoring in heart failure.
    Rathman L; Repoley J; Delgado S; Trupp R
    J Cardiovasc Nurs; 2008; 23(2):159-68. PubMed ID: 18382259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure.
    Vanderheyden M; Houben R; Verstreken S; Ståhlberg M; Reiters P; Kessels R; Braunschweig F
    Circ Heart Fail; 2010 May; 3(3):370-7. PubMed ID: 20197559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of implantable hemodynamic monitoring in the management of patients with diastolic heart failure: a subgroup analysis of the COMPASS-HF trial.
    Zile MR; Bourge RC; Bennett TD; Stevenson LW; Cho YK; Adamson PB; Aaron MF; Aranda JM; Abraham WT; Smart FW; Kueffer FJ
    J Card Fail; 2008 Dec; 14(10):816-23. PubMed ID: 19041044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of preclinical body fluid retention in established heart failure patients during follow-up by a digital weight scale incorporating a bioelectrical impedance analyzer.
    Kataoka H
    Congest Heart Fail; 2012; 18(1):37-42. PubMed ID: 22277176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and performance of a multisensor heart failure monitoring algorithm: results from the multisensor monitoring in congestive heart failure (MUSIC) study.
    Anand IS; Tang WH; Greenberg BH; Chakravarthy N; Libbus I; Katra RP;
    J Card Fail; 2012 Apr; 18(4):289-95. PubMed ID: 22464769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial.
    Hawkins NM; MacDonald MR; Petrie MC; Chalmers GW; Carter R; Dunn FG; McMurray JJ
    Eur J Heart Fail; 2009 Jul; 11(7):684-90. PubMed ID: 19460848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.